<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other></Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><strain>GGCC_0306</strain><center_name>Gusto Global LLC</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA628684</full_dataset_link><scientific_name>Barnesiella sp. GGCC_0306</scientific_name><long_description>Barnesiella sp. GGCC_0306 is a member of GUT-108, a consortium of commensal bacteria rationally designed around functionalities that are underrepresented in the gut microbiome of IBD patients. When therapeutically applied in a humanized mouse model, GUT-108 robustly corrected colitis-related microbial dysbiosis, dysregulated metabolism and reduced T cell-mediated colitis.</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Barnesiella sp. GGCC_0306</name><description>Barnesiella sp. GGCC_0306 Genome sequencing and assembly</description><dates><last_updated>2025-09-24</last_updated><first_public>2021-03-30</first_public></dates><accession>PRJNA628684</accession><cross_references><taxon>2731211</taxon></cross_references></HashMap>